3.11
price down icon4.01%   -0.13
 
loading
전일 마감가:
$3.24
열려 있는:
$3.23
하루 거래량:
1.45M
Relative Volume:
1.76
시가총액:
$257.65M
수익:
$70.14M
순이익/손실:
$-76.24M
주가수익비율:
-2.8018
EPS:
-1.11
순현금흐름:
$-57.06M
1주 성능:
+10.28%
1개월 성능:
+23.90%
6개월 성능:
-36.66%
1년 성능:
-14.79%
1일 변동 폭
Value
$3.01
$3.23
1주일 범위
Value
$2.81
$3.38
52주 변동 폭
Value
$1.90
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
명칭
Codexis Inc
Name
전화
650-421-8100
Name
주소
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
직원
188
Name
트위터
@codexisinc
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
CDXS's Discussions on Twitter

CDXS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CDXS
Codexis Inc
3.11 268.42M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-19 다운그레이드 The Benchmark Company Buy → Hold
2024-06-03 재개 Jefferies Buy
2024-05-30 개시 Cantor Fitzgerald Overweight
2024-02-29 업그레이드 The Benchmark Company Hold → Buy
2023-11-07 다운그레이드 The Benchmark Company Buy → Hold
2023-08-07 다운그레이드 TD Cowen Outperform → Market Perform
2023-05-09 다운그레이드 H.C. Wainwright Buy → Neutral
2022-03-31 재개 Piper Sandler Overweight
2022-03-02 재개 Cowen Outperform
2021-04-12 개시 Piper Sandler Overweight
2021-03-01 개시 Stifel Buy
2021-02-26 재확인 H.C. Wainwright Buy
2020-03-10 개시 The Benchmark Company Buy
2019-01-17 업그레이드 First Analysis Sec Neutral → Outperform
2018-05-16 개시 Stephens Overweight
2017-10-13 재확인 H.C. Wainwright Buy
2017-05-31 개시 Jefferies Buy
2017-01-26 다운그레이드 First Analysis Sec Overweight → Equal-Weight
2017-01-04 업그레이드 Ladenburg Thalmann Neutral → Buy
2016-01-06 개시 H.C. Wainwright Buy
모두보기

Codexis Inc 주식(CDXS)의 최신 뉴스

pulisher
Jul 25, 2025

What makes Codexis Inc. stock price move sharplyVolume Spike Monitors - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Codexis Confronts Trade Policy Challenges: Tariffs and Sanctions Threaten Operations - TipRanks

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is Codexis Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Why Codexis Inc. stock attracts strong analyst attention3x Return Stock Radar - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

How Codexis Inc. stock compares to its top competitorsIs CNFRZ stock undervalued or overvalued nowSignificant capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Codexis Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Codexis Inc. stock priceExceptional gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

How Codexis Inc. stock performs during market volatilityFree Market Analysis Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Biocatalysis And Biocatalyst Market Set for Strong Growth Outlook: Codexis, Amano Enzyme, Biocatalysts - newstrail.com

Jul 15, 2025
pulisher
Jul 11, 2025

Codexis, Inc.'s (NASDAQ:CDXS) P/S Is Still On The Mark Following 27% Share Price Bounce - 富途牛牛

Jul 11, 2025
pulisher
Jul 03, 2025

What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S - simplywall.st

Jul 03, 2025
pulisher
Jun 27, 2025

With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo.co

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Synthetic Biology Market Key Players AnalysisBota - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks

Jun 16, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 08, 2025

Codexis Inc (CDXS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):